Greenstein Trading Holding

Greenstein Trading & Holding Ltd is an Israeli-based private holding and investment company primarily focused on the biotechnology, medical device, and life sciences sectors. The company acts as a strategic investment vehicle for the Greenstein family, specializing in identifying and developing innovative healthcare technologies within the Israeli ecosystem. GTH's portfolio has historically included significant stakes in companies such as Exalenz Bioscience, a provider of advanced breath-testing diagnostics for gastrointestinal and liver conditions, and Vaxil Bio, which develops immunotherapy-based cancer vaccines. The firm also maintains interests in digital health ventures like GlucoMe, a comprehensive diabetes management platform. By providing capital and strategic oversight, Greenstein Trading & Holding supports its portfolio companies from early-stage research and development through to international commercialization and strategic exit events.